The groundbreaking ultrasound technology chosen by NASA, NIH (COPD Gene Study), and NIOSH to monitor pulmonary function. With 40 percent of the U.S. spirometry market share, ndd Medical Technologies ...
The groundbreaking ultrasound technology chosen by NASA, NIH (COPD Gene Study), and NIOSH to monitor pulmonary function. With 40 percent of the U.S. spirometry market share, ndd Medical Technologies offers innovative, easy-to-use pulmonary function testing instruments that help clinicians diagnose and treat lung disease with greater precision. Its EasyOne® portable instruments take lung testing wherever it is needed, measuring DLCO, FRC, LCI and FVC. ndd's patented Ultrasonic TrueFlow™ technology eliminates problems associated with traditional methods of flow measurement, making testing fast, reliable and error free. To learn more, visit www.nddmed.com. Experts in Lung Function.